Viruses, Vol. 15, Pages 1704: Compartmentalized Regulation of Pulmonary and Systemic Inflammation in Critical COVID-19 Patients

Viruses, Vol. 15, Pages 1704: Compartmentalized Regulation of Pulmonary and Systemic Inflammation in Critical COVID-19 Patients

Viruses doi: 10.3390/v15081704

Authors: Luciana Santiago Marcela Helena Gonçalves-Pereira Mariana Sousa Vieira Cecilia Gómez Ravetti Paula Frizera Vassallo Rafael Silva e Castro Pedro Pires Costa Pimenta Marcus Vinícius Melo de Andrade Helton da Costa Santiago Vandack Nobre

Critical COVID-19 has been associated with altered patterns of cytokines. Distinct inflammatory processes in systemic and pulmonary sites have been reported, but studies comparing these two sites are still scarce. We aimed to evaluate the profile of pulmonary and systemic cytokines and chemokines in critically ill COVID-19 patients. Levels of cytokines and chemokines were measured in plasma samples and minibronchoalveolar lavage of critical COVID-19 patients within 48 h and 5–8 days after intubation. Distinct inflammatory processes were observed in the lungs and blood, which were regulated separately. Survivor patients showed higher lung cytokine levels including IFN-γ, IL-2, IL-4, G-CSF, and CCL4, while nonsurvivors displayed higher levels in the blood, which included IL-6, CXCL8, CXCL10, CCL2, and CCL4. Furthermore, our findings indicate that high TNF and CXCL8 levels in the mini-BAL were associated with better lung oxygen exchange capacity, whereas high levels of IFN-γ in plasma were associated with worse lung function, as measured using the PaO2/FiO2 ratio. These results suggest that a robust and localized inflammatory response in the lungs is protective and associated with survival, whereas a systemic inflammatory response is detrimental and associated with mortality in critical COVID-19.